Analystreport

Cellectar Biosciences Inc (NASDAQ: CLRB) was given a new $3.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

Cellectar Biosciences, Inc.  (CLRB) 
Last cellectar biosciences, inc. earnings: 11/12 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.cellectar.com